UK MORNING BRIEFING: Shares Down; Land Securities Buys Into Bluewater
25th Jun 2014 07:40
LONDON (Alliance News) - The following is a summary of top news stories Thursday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Rolls-Royce</strong> Holdings PLC moved to appease investors unhappy with the company's recent outlook downgrade, saying it will return Read More
LONDON (Alliance News) - UK shares have opened strongly higher Thursday, and the pound has broken above USD1.70, following a well-received US Federal Reserve meeting.<br /><br /><strong>Rolls-Royce</strong> Holdings leads FTSE 100 gains after saying it will return cash to shareholders through Read More
LONDON (Alliance News) - Carillion PLC, Balfour Beatty PLC, Costain Group PLC and a joint venture including Morgan Sindall Group PLC Thursday won a GBP184 million contract to upgrade the M60 and M62 motorways around Manchestet, as Carillion also said it has now signed a GBP200 million support ser Read More
LONDON (Alliance News) - UK shares have opened higher Wednesday, following a firm close on Wall Street and ahead of central bank announcements in the UK and US.<br /><br />There was further IPO activity Wednesday, as property website <strong>Zoopla Property</strong> Group said it will price it Read More
LONDON (Alliance News) - Balfour Beatty PLC Wednesday said it has been awarded a USD156.0 million design-and-build contract to construct a new headquarters for the National Science Foundation in the US state of Virginia, which the construction contractor says is evidence of a recovering market in Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>Whitbread</strong>, up 3.1%. The Premier Inn hotels and Costa Coffee chain operator re Read More
LONDON (Alliance News) - UK shares have opened higher Tuesday, encouraged by a positive close on Wall Street on Monday and ahead of UK inflation data.<br /><br /><strong>Whitbread</strong> leads FTSE 100 gainers, as it said its Premier Inn hotels and Costa Coffee shops continued their strong s Read More
LONDON (Alliance News) - Balfour Beatty PLC Tuesday said its joint venture has been named "selected bidder" for two new acute care hospitals in Vancouver, British Columbia continuing its move into the Canadian healthcare market. In a statement, the construction company said that the 30-year Read More
LONDON (Alliance News) - Construction company Balfour Beatty PLC said Monday a group of executives including Chief Financial Officer Duncan Magrath acquired shares at 240 pence each under the company's share incentive plan Thursday. <br /><br />The transactions were as follows:<br /><br /> Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>ITV</strong>, up 2.7%. ITV's shares have spent June trading in tight ranges, and Libe Read More
LONDON (Alliance News) - Construction companies Balfour Beatty PLC, Carillion PLC and Galliford Try PLC Thursday said they have been selected as preferred bidders to finance, design build and operate the GBP745 million Aberdeen Western Peripheral Route/Balmedie to Tipperty road project. The Read More
LONDON (Alliance News) - UK shares have opened flat Thursday, following negative trading in the US and Asia overnight. <br /><br /><strong>AstraZeneca</strong> is the third biggest gainer on the FTSE 100. The drugmaker said it has signed a global licence agreement with AIM-listed biotechnology Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning and Monday afternoon:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />SOCGEN RAISES WEIR GROUP TO 'HOLD' ('SELL') - TARGET 2600 (2300) PENCE <br />----------<br />TRADERS: EXAN Read More
LONDON (Alliance News) - <strong>GlaxoSmithKline</strong> has signed a collaboration and licensing agreement with UK-based biotechnology company Adaptimmune Ltd for its cancer programme, a move that comes just weeks after it agreed to sell its own cancer drug business to Novartis as part of a Read More